| Literature DB >> 32922504 |
Mateusz Wojciech Romanowski1,2,3, Maja Špiritović4, Wojciech Romanowski2, Anna Straburzyńska-Lupa2,5.
Abstract
OBJECTIVES: The purpose of this study was to evaluate the impact of manual therapy on the management of rheumatoid arthritis (RA) patients with knee pain.Entities:
Year: 2020 PMID: 32922504 PMCID: PMC7453239 DOI: 10.1155/2020/1452579
Source DB: PubMed Journal: Evid Based Complement Alternat Med ISSN: 1741-427X Impact factor: 2.629
Criteria for inclusion and exclusion.
| Inclusion in the study | Exclusion from the study |
|---|---|
| Diagnosis of RA | Change in dosage of nonsteroidal anti-inflammatory drugs and corticosteroids for 2 weeks before the beginning of the study and for the duration of the study |
| Age range: participants had to be of 18 years or above | Change in dosage of the disease-modifying synthetic and biologics antirheumatic drugs for 3 months before the beginning of the study and for the duration of the study |
| Experience daily pain of one knee (VAS ≥4) with power Doppler ultrasonography ≤ grade 1 | Injection of a local anaesthetic and steroids for 1 month before the beginning of the study and for the duration of the study |
| DAS28 ≤ 5.1 | Every recent surgery in the past 6 months |
| Informed consent for participation in the study, signed by the patient | History of knee joint replacement in the treated knee |
| Neurological signs present | |
| Experience daily pain of both knees | |
| Chronic bone damage | |
| Soft tissue injuries in the knee | |
| Acute inflammation within the latest week in any joint of lower limb joints | |
| Pregnancy | |
| Fever |
Figure 1Trial profile.
Baseline characteristics of the 46 patients with knee pain and with rheumatoid arthritis.
| Manual therapy group ( | Control group ( |
|
| |
|---|---|---|---|---|
| Age (years) | 59.7 (12.15) | 57.7 (8.00) | 0.66 | 0.5131 |
| Body mass (kg) | 75.9 (12.20) | 70.3 (16.20) | 1.33 | 0.1917 |
| Body height (cm) | 159.4 (8.30) | 160.0 (5.87) | −0.33 | 0.7444 |
| DAS28 | 4.66 (0.43) | 4.31 (0.90) | 1.12 | 0.2289 |
| BMI (kg/m2) | 30.1 (5.49) | 27.5 (6.61) | 1.41 | 0.1649 |
| NSAID ( | 16 | 17 | ||
| DMARDsynthetic ( | 11 | 13 |
| 0.8972 |
| DMARDbiologics ( | 7 | 6 |
The results are expressed as mean (SD); BMI: body mass index; DAS 28: disease activity score; VAS: visual analog scale; NSAID: nonsteroidal anti-inflamatory drugs; DMARDs: disease-modifying antirheumatic drugs; p: p values.
Figure 2Mean score differences over time according to group allocation using intention to treat analysis. (a) VAS. (b) OKS. (c) KKS. and (d) HAQ.
Mean score differences over time according to group allocation using intention to treat analysis.
| Manual therapy group | Control group | ANOVA | |||||
|---|---|---|---|---|---|---|---|
| Before | After | Before | After |
| |||
| Group | Time | Interaction | |||||
| VAS | 71.43 (12.52) | 35.65 (12.15) | 62.26 (10.50) | 47.04 (17.52) | 0.739 | <0.001 | <0.001 |
| OKS | 23.70 (7.29) | 31.50 (26.78) | 24.00 (5.82) | 29.10 (35.71) | 0.559 | <0.001 | 0.052 |
| KKS | 59.61 (12.94) | 74.70 (10.15) | 61.80 (37.08) | 68.87 (10.71) | 0.518 | <0.001 | 0.004 |
| HAQ | 1.30 (60.57) | 1.00 (40.44) | 1.30 (10.46) | 1.00 (30.42) | 0.811 | <0.001 | 0.696 |
The results are expressed as mean and standard deviation (SD); VAS: visual analog scale; KSS: Knee Society Score; OKS: Oxford Knee Score; HAQ: Health Assessment Questionnaire; p: p values p < 0.001; p < 0.01; p < 0.05.